Immunity is a self-proclaimed heroic battalion that defends the body’s territory. When invaders approach, it deploys with fanfare, yet often fails to discern friend from foe before attacking. It moonlights as a cascade strike unit capable of collateral damage against its own homeland. It hides in obscurity during peacetime, emerging only in crisis to bask in fleeting praise.

Immunotherapy is a cutting-edge trick that turns your immune system into front-line soldiers, transforming your body into a battlefield to annihilate cancer cells or viruses. Instead of simply fighting disease, it orchestrates an in-house royal rumble of cells, leaving spectators to witness the merciless reality known as side effects. Praising the progress of science, it orders your white blood cells into overwork, resembling the reckless ambition of a biotech startup. Caught between hope of cure and despair, patients watch their own bodies betray them. It’s medical entertainment with a gamble emerging from beneath the guise of advanced healthcare.

Immunotherapy is a modern medical spectacle that declares your body a battlefield and upgrades immune cells into genetically engineered soldiers. These warriors occasionally go rogue, attacking healthy tissue as collateral damage, but setbacks are politely rebranded as 'unanticipated side effects.' Drug companies hail it as 'breakthrough,' clinicians dub it the 'trump card,' and patients willingly ingest both hope and dread in equal measure. The treatment's success depends on cellular moods, elevating victors to Nobel contenders and sentencing failures to the dumpster of wasted healthcare spending. At its core, immunotherapy may be little more than a high-priced gamble peddling dreams and risks in equal proportion.

Immutability is the mental tic of turning one’s back on change and worshipping bygone habits. It proclaims eternity while kicking reality’s progress to the curb. A paradoxical creed that sanctifies denial of flux to safeguard one’s own position.

Impact investing is the ceremony where social goodwill and financial return briefly exchange vows. Armed with the catchphrase 'save profits and society,' investors bury ambiguous outcomes beneath mounds of reports. The anticipated return? A few percentage points, a flood of social media praise, or perhaps both. On the ground, target metrics and the goalposts of benevolence perpetually recede, leaving achievement unmeasured. It is a global magic show that simultaneously liquidates budgets in the name of altruism and manages investor self-esteem.

Impact investment is the magic trick of simultaneously tickling investors’ wallets and consciences under the grand banner of saving the planet and future. It purports to deploy capital to rescue the world but often ends up as the marketing department’s holy grail. It preaches the twin dogmas of “returns” and “goodwill,” yet returns always come first. Social impact is frequently adorned in PowerPoint slides while in reality it lurks as a footnote beside profit calculations. Investors watching their portfolio companies look more like profit seekers than philanthropists.

Impairment is the art of stealthily discarding the burdens called value at the fiscal year end. It is the magical ritual of erasing inconvenient numbers from the balance sheet stage. Welcomed by investors as a carefully disguised “health” indicator, it secretly transmutes red ink into an invisible serpent. It sums up the gap between corporate optimism and reality in one line, offering executives the perfect opportunity to test their creative excuses.

Impasto is less about applying paint and more about heaping it, a crystalline monument to the artist’s ego. Its peaks and valleys lure light and shadow, offering the viewer the thrill of potential collapse and the illusion that thick paint might actually speak. Lauded in art history as the moment emotion became tangible, it is often simply over-applied makeup. In essence, it’s a hybrid of playfulness and bravado masquerading as technique.

A dazzling spectacle of power struggle wherein the nation's highest leader is dragged onto a courtroom stage. A ceremony to strip away honor and trust, yet often reduced to a political show for the voters. The cannons of accusations fired along the way target ambition more than justice. Marketed as a triumph for winners or a drama of disgrace-avoidance for losers, its finale usually sees the curtains drawn on public exhaustion. It's democracy’s favorite illusion: the promise of accountability sold as grand entertainment.

An import quota is a veil of protectionism dancing on the altar of free trade proclaimed by governments, ostensibly controlling foreign currency outflow while imprisoning consumer purchasing power in a purgatory. The regulation, adorned with the euphemism 'industry support,' ironically distorts the market and tramples on the ethics of efficiency. Granting respite to domestic firms while delivering remorse to consumers, this system is merely a conceptual stage prop played out on the international economic scene. Countless permits, masquerading as symbols of fairness, are in reality nothing more than tools for power-driven transaction blackouts.

Impressionism is the grand scheme of painters who discard clear outlines and worship fleeting sensations. They proclaim the interplay of light and color as a noble excuse for vagueness. Viewers are conscripted to complete the work, while artists revel in blaming the wind for their blurred strokes. Critics then laud the haze, turning ambiguity into a marketing device. Ultimately, it remains a business model swayed by buyers’ pockets and tomorrow’s weather forecast.

Improvement is the utopian theory born to multiply documents while neglecting the real site. In principle, every perfected procedure only summons new meetings and checklists, becoming a fetter on the status quo. Under the banner of improvement, organizations worship an endless ritual of report creation that never ends. Rarely does it work, only when dissatisfaction miraculously subsides for a moment. Ultimately, improvement is merely a slogan celebrating change and the smartest excuse for maintaining the status quo.